Trading Signals: TGTX Stock Price Prediction and Forecast (Mon. Aug. 10, 2015 - Wed. Sep. 14, 2022)(TG Therapeutics Inc)
| TGTX latest price $6.1700 (-0.08%) ($6.1700 - $6.1700) on Sun. Jul. 17, 2022. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 7.47% (three month average) | RSI | 76 | Latest Price | $6.1700(-0.08%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | TGTX advances 1.9% a day on average for past five trading days. | Weekly Trend | TGTX advances 16.5% a week on average for past two weeks. | Market Behavior | Normal for large cap. Normal for small cap. | Correlated ETFs | Broad market will support TGTX advance at 0% a week (0% probability) (0%) (0%) (0%) (0%) (0%) | Factors Impacting TGTX price | TGTX will decline at least -3.735% in a week (0% probabilities). (0%) (0%) (0%) (0%) (0%) | Explanation | The rally is not sustainable and not supported by the broad market. | | | | | Relative Volatility | | | | Market Trend Strength | -3.735% (StdDev 7.47%) | Hourly BBV | 0 () | Intraday Trend | 0% | | | |
|
5 Day Moving Average | $5.86(5.29%) | 10 Day Moving Average | $5.58(10.57%) | 20 Day Moving Average | $4.94(24.9%) | To recent high | -22% | To recent low | 65.2% | Market Cap | $N/A | | | | TG Therapeutics, Inc. is a biopharmaceutical company, which engages in the acquisition, development, and commercialization of novel treatments for B-cell malignancies and autoimmune diseases. Its product pipeline includes TG-1101, Ublituximab, and Umbralisib. The company was founded by Michael Sean Weiss and Laurence H. Shaw on May 18, 1993 and is headquartered in New York, NY. |